140 related articles for article (PubMed ID: 38837761)
1. Trends in management of patients with new-onset refractory status epilepticus (NORSE) from 2016 to 2023: An interim analysis.
Hanin A; Jimenez AD; Gopaul M; Asbell H; Aydemir S; Basha MM; Batra A; Damien C; Day GS; Eka O; Eschbach K; Fatima S; Fields MC; Foreman B; Gerard EE; Gofton TE; Haider HA; Hantus ST; Hocker S; Jongeling A; Kalkach Aparicio M; Kandula P; Kang P; Kazazian K; Kellogg MA; Kim M; Lee JW; Marcuse LV; McGraw CM; Mohamed W; Orozco J; Pimentel CM; Punia V; Ramirez AM; Steriade C; Struck AF; Taraschenko O; Treister AK; Wainwright MS; Yoo JY; Zafar S; Zhou DJ; Zutshi D; Gaspard N; Hirsch LJ
Epilepsia; 2024 Jun; ():. PubMed ID: 38837761
[TBL] [Abstract][Full Text] [Related]
2. Second-line immunotherapy in new onset refractory status epilepticus.
Hanin A; Muscal E; Hirsch LJ
Epilepsia; 2024 May; 65(5):1203-1223. PubMed ID: 38430119
[TBL] [Abstract][Full Text] [Related]
3. A practical approach to in-hospital management of new-onset refractory status epilepticus/febrile infection related epilepsy syndrome.
Sheikh Z; Hirsch LJ
Front Neurol; 2023; 14():1150496. PubMed ID: 37251223
[TBL] [Abstract][Full Text] [Related]
4. Ketogenic diet for super-refractory status epilepticus (SRSE) with NORSE and FIRES: Single tertiary center experience and literature data.
Nabbout R; Matricardi S; De Liso P; Dulac O; Oualha M
Front Neurol; 2023; 14():1134827. PubMed ID: 37122314
[TBL] [Abstract][Full Text] [Related]
5. Comparative analysis of patients with new onset refractory status epilepticus preceded by fever (febrile infection-related epilepsy syndrome) versus without prior fever: An interim analysis.
Jimenez AD; Gopaul M; Asbell H; Aydemir S; Basha MM; Batra A; Damien C; Day GS; Eka O; Eschbach K; Fatima S; Fields MC; Foreman B; Gerard EE; Gofton TE; Haider HA; Hantus ST; Hocker S; Jongeling A; Kalkach Aparicio M; Kandula P; Kang P; Kazazian K; Kellogg MA; Kim M; Lee JW; Marcuse LV; McGraw CM; Mohamed W; Orozco J; Pimentel C; Punia V; Ramirez AM; Steriade C; Struck AF; Taraschenko O; Treister AK; Yoo JY; Zafar S; Zhou DJ; Zutshi D; Gaspard N; Hirsch LJ; Hanin A
Epilepsia; 2024 Jun; 65(6):e87-e96. PubMed ID: 38625055
[TBL] [Abstract][Full Text] [Related]
6. Clinical presentation of new onset refractory status epilepticus in children (the pSERG cohort).
Sculier C; Barcia Aguilar C; Gaspard N; Gaínza-Lein M; Sánchez Fernández I; Amengual-Gual M; Anderson A; Arya R; Burrows BT; Brenton JN; Carpenter JL; Chapman KE; Clark J; Gaillard WD; Glauser TA; Goldstein JL; Goodkin HP; Gorman M; Lai YC; McDonough TL; Mikati MA; Nayak A; Peariso K; Riviello J; Rusie A; Sperberg K; Stredny CM; Tasker RC; Tchapyjnikov D; Vasquez A; Wainwright MS; Wilfong AA; Williams K; Loddenkemper T;
Epilepsia; 2021 Jul; 62(7):1629-1642. PubMed ID: 34091885
[TBL] [Abstract][Full Text] [Related]
7. Febrile Infection-Related Epilepsy Syndrome (FIRES): An Overview of Treatment and Recent Patents.
Hon KL; Leung AKC; Torres AR
Recent Pat Inflamm Allergy Drug Discov; 2018; 12(2):128-135. PubMed ID: 29745347
[TBL] [Abstract][Full Text] [Related]
8. International consensus recommendations for management of New Onset Refractory Status Epilepticus (NORSE) incl. Febrile Infection-Related Epilepsy Syndrome (FIRES): Statements and Supporting Evidence.
Wickstrom R; Taraschenko O; Dilena R; Payne ET; Specchio N; Nabbout R; Koh S; Gaspard N; Hirsch LJ;
Epilepsia; 2022 Aug; 63(11):2840-64. PubMed ID: 35997591
[TBL] [Abstract][Full Text] [Related]
9. A retrospective study of 92 children with new-onset refractory status epilepticus.
Wu J; Lan X; Yan L; Hu Y; Hong S; Jiang L; Chen J
Epilepsy Behav; 2021 Dec; 125():108413. PubMed ID: 34794014
[TBL] [Abstract][Full Text] [Related]
10. New-onset refractory status epilepticus (NORSE) and febrile infection-related epilepsy syndrome (FIRES): State of the art and perspectives.
Gaspard N; Hirsch LJ; Sculier C; Loddenkemper T; van Baalen A; Lancrenon J; Emmery M; Specchio N; Farias-Moeller R; Wong N; Nabbout R
Epilepsia; 2018 Apr; 59(4):745-752. PubMed ID: 29476535
[TBL] [Abstract][Full Text] [Related]
11. New-onset refractory status epilepticus (NORSE)--The potential role for immunotherapy.
Khawaja AM; DeWolfe JL; Miller DW; Szaflarski JP
Epilepsy Behav; 2015 Jun; 47():17-23. PubMed ID: 26010959
[TBL] [Abstract][Full Text] [Related]
12. New onset refractory status epilepticus (NORSE).
Sculier C; Gaspard N
Seizure; 2019 May; 68():72-78. PubMed ID: 30482654
[TBL] [Abstract][Full Text] [Related]
13. New-onset refractory status epilepticus (NORSE) and febrile infection-related epilepsy syndrome (FIRES) of unknown aetiology: A comparison of the incomparable?
Nausch E; Schaffeldt L; Tautorat I; Margraf NG; Häusler M; Kluger G; Kellinghaus C; Borzikowsky C; Laufs H; van Baalen A
Seizure; 2022 Mar; 96():18-21. PubMed ID: 35042004
[TBL] [Abstract][Full Text] [Related]
14. A retrospective cohort study of new-onset refractory status epilepticus (NORSE): clinical features, timing of immunotherapy and outcomes.
Werbaneth K; Mausolf M; Seliger J; Le S
Epileptic Disord; 2022 Oct; 24(5):867-876. PubMed ID: 35892128
[TBL] [Abstract][Full Text] [Related]
15. How to Help Your Patients Enroll in the New-Onset Refractory Status Epilepticus (NORSE) and Febrile Infection-Related Epilepsy Syndrome (FIRES) Family Registry, and Other Rare Epilepsy Registries.
Kazazian K; Kellogg M; Wong N; Eschbach K; Moeller RF; Gaspard N; Hirsch LJ; Hocker S; Gofton T
Epilepsy Curr; 2021 Mar; ():1535759721998329. PubMed ID: 33663265
[TBL] [Abstract][Full Text] [Related]
16. International consensus recommendations for management of New Onset Refractory Status Epilepticus (NORSE) including Febrile Infection-Related Epilepsy Syndrome (FIRES): Summary and Clinical Tools.
Wickstrom R; Taraschenko O; Dilena R; Payne ET; Specchio N; Nabbout R; Koh S; Gaspard N; Hirsch LJ;
Epilepsia; 2022 Aug; 63(11):2827-39. PubMed ID: 35951466
[TBL] [Abstract][Full Text] [Related]
17. A favorable outcome of intensive immunotherapies for new-onset refractory status epilepticus (NORSE).
Kodama S; Arai N; Hagiwara A; Kimura A; Takeuchi S
J Intensive Care; 2018; 6():43. PubMed ID: 30083346
[TBL] [Abstract][Full Text] [Related]
18. Proposed consensus definitions for new-onset refractory status epilepticus (NORSE), febrile infection-related epilepsy syndrome (FIRES), and related conditions.
Hirsch LJ; Gaspard N; van Baalen A; Nabbout R; Demeret S; Loddenkemper T; Navarro V; Specchio N; Lagae L; Rossetti AO; Hocker S; Gofton TE; Abend NS; Gilmore EJ; Hahn C; Khosravani H; Rosenow F; Trinka E
Epilepsia; 2018 Apr; 59(4):739-744. PubMed ID: 29399791
[TBL] [Abstract][Full Text] [Related]
19. The etiology and mortality of new-onset refractory status epilepticus (NORSE) in adults: A systematic review and meta-analysis.
Tharmaraja T; Ho JSY; Neligan A; Rajakulendran S
Epilepsia; 2023 May; 64(5):1113-1124. PubMed ID: 36727541
[TBL] [Abstract][Full Text] [Related]
20. Early clinical features of new-onset refractory status epilepticus (NORSE) in adults.
Haanpää A; Laakso SM; Kinnunen A; Kämppi L; Forss N
BMC Neurol; 2022 Dec; 22(1):495. PubMed ID: 36539824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
